News Sentiment

OBI sentiment intelligence

Ondine Biomedical Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 2 relevant articles
Exchange LSE United Kingdom
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.15 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

75/100 classification confidence.

Company focus 2

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-2.7% over one week, +11.5% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Ondine Biomedical highlights progress on Lantern phase 3 study

Market Reaction

Balanced read

56/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 75/100 classification
One-week reaction -2.7% Price reacting lower
Trend fit Trend active 11.5% over four weeks
Fair value 40.0% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 2
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 2
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
London South East 1
MarketBeat 1

Event Lens

What the news is about

Classified themes
Market update 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-2 of 2